Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Discontinued insulin pump therapy

Researcher profiles:
Associate Professor Ben Wheeler (PI)
Associate Professor Rhiannon Braund
Associate Professor Barbara Galland
Dr Matt Healey
Dr Jinny Willis
• Associate Professor Craig Jefferies
Dr Sarah Boucher

Identifying demographic characteristics of patients who discontinue insulin pump therapy

Insulin pump therapy is publicly funded in New Zealand via the special authority scheme set out by the New Zealand Pharmaceutical Management Agency (PHARMAC). Patients must meet certain criteria in order to obtain government funding for their insulin pump. They also have to reapply in nine months to renew this eligibility. If patients fail to meet certain treatment targets as specified by PHARMAC, they may have their insulin pump therapy funding taken away.

This project aims to identify groups who may be more likely to not succeed with insulin pump therapy, and expect that characteristics such as age, ethnicity, and deprivation will be associated. Identifying demographic characteristics of patients who discontinue insulin pump therapy will enable us to offer targeted education or more support to ensure patients success with this important but expensive therapy.